Diagnostic Biomarkers in Metabolomics

A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. A biomarker reveals further information to presently existing clinical and pathological analysis. It facilitates screening and detecting the disease, monitoring the progression of the disease, and predicting the diagnosis and survival after clinical intervention. A biomarker can also be used to evaluate the process of drug development and optimally to improve the efficacy and safety of disease treatment by enabling physicians to tailor treatment for individual patients. These emerging biomarkers will be beneficial and critical in developing new and clinically reliable indicators that will have a high specificity for the diagnosis.

  • Metabolite platform for validation of biomarkers
  • Biomarkers in drug development
  • Disease related biomarkers
  • Imaging biomarkers
  • Metabolomics in biomarker discovery

Related Conference of Diagnostic Biomarkers in Metabolomics

May 10-11, 2019

13th International Conference on Proteomics, Genomics and Bioinformatics

| Radisson Hotel Narita | Tokyo, Japan
May 10-11, 2019

8th Asia Pacific Glycobiology Congress

Tokyo, Japan
May 17-18, 2019

2nd International Conference on Computational Biology and Bioinformatics

| Holiday Inn Singapore Atrium | Singapore
July 11-12, 2019

8th Glycobiology World Congress

Zurich, Switzerland
May 10-11, 2019

4th International Conference on Enzymology & Molecular Biology

| Radisson Hotel Narita | Tokyo, Japan
October 07-08, 2019

4th International Conference on Molecular Biology & Nucleic Acids

Chicago, Illinois, USA

Diagnostic Biomarkers in Metabolomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in